NIH Director's COVID Comments Spark Staff Walkout
By I. Edwards HealthDay Reporter
TUESDAY, May 27, 2025 — Dozens of staff at the U.S. National Institutes of Health (NIH) walked out of a recent town hall meeting after Director Dr. Jay Bhattacharya suggested the agency may have helped fund research that caused the COVID-19 pandemic.
The protest happened roughly 27 minutes into the meeting, held at NIH headquarters in Bethesda, Md.
In a video obtained by CNN, Bhattacharya is shown telling staff that, based on his review of scientific evidence and public opinion polling, he believed COVID may have started due to research funded, in part, by the NIH.
"It’s possible that the pandemic was caused by research conducted by human beings," Bhattacharya said. "And it’s also possible that the NIH partly sponsored that research. And if that’s true — ”
At that point, dozens of NIH employees walked out. Bhattacharya called the walkout "silent dissent" and continued on with the meeting.
Many of the protestors, according to CNN, were postdoctoral researchers and members of the NIH union.
They said the walkout was planned, though the timing was moved up after Bhattacharya's controversial comments.
"We were trying to use this walkout as a way to get a sit-down meeting with Dr. Bhattacharya," Matt Manion, a postdoctoral researcher, said.
He and others described worsening work conditions under the Trump administration.
Staff said their research has been disrupted by reductions in purchasing staff, the firing and rehiring of colleagues and the specter of a 40% cut to the NIH budget.
Kaitlyn Hajdarovic, another researcher, told CNN union members had been trying to meet with Bhattacharya to discuss issues "that prevented us from doing our jobs and research."
Further, some staff were also upset about a new policy that bars grant recipients from sharing funding with foreign collaborators — a move they say could hurt research and future pandemic prevention.
The White House's proposed 2026 budget cites NIH funding of research at the Wuhan Institute of Virology as a reason for a nearly $18 billion budget cut. President Donald Trump has said he believes the COVID virus originated there.
“Whether or not you agree with the theory, foreign subawards support research to prevent the next pandemic,” one scientist said anonymously “Canceling them all at once with little to no warning is asking for another pandemic.”
At the town hall, Bhattacharya also addressed controversial topics like diversity, equity and inclusion, also known as DEI, in research.
He said he supported studies on issues like redlining, or racial discrimination in housing and lending practices, and access to care, but questioned research that claimed, without clear proof, that structural racism causes poor health outcomes.
Tension grew when an audience member challenged him directly, CNN reported.
Bhattacharya acknowledged later that he took office the same day 1,200 NIH staff were laid off.
“I actually don’t have any transparency in how those decisions were made," he said. "And I was quite upset about that. It would be nice to have had some say.”
He also mentioned ending a requirement imposed by Elon Musk, then a senior adviser to Trump, for scientists to send weekly emails listing five accomplishments from the week.
"That was ridiculous," he said, to a round of applause. "I’m really flat proud that we don’t have to have some of the best scientists in the world tell me what they did last week with five points. That made no sense.”
A week after the town hall, union members said they had not yet heard back from Bhattacharya’s office to schedule a meeting.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-28 06:00
Read more

- 72 Percent of Infants Immunized Against Respiratory Syncytial Virus
- Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission
- Childhood High Blood Sugar Can Cause Heart Problems In Young Adults
- Concussion? When To Start Physical Therapy
- IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
- Exercise Improves Odds Against Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions